Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-24-001995

Chief Financial Officer acquired 82,220 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Carulli Michael Chief Financial Officer 2024-01-18 Grant or award +82,220 91,286 D
Derivatives
Carulli Michael Chief Financial Officer 2024-01-18 Grant or award · Employee Stock Option (right to buy) +204,630 204,630 D
Loading xslF345X05/doc4.xml…